Delivery Order SPE2DB22D1103-SPE2DB25FTQB7
Award Date
6/17/25
Potential Completion Date
6/18/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of a specific pharmaceutical product, DAPAGLIFLOZIN 10 MG TABLET 30S. The contract has a ceiling value of $9,867.26 and is a firm fixed price delivery order contract, with a completion date of June 6, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. The contract has a ceiling value of $12,122.96 and an ultimate completion date of June 12, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication, with a ceiling value of $22,799.14 and a period of performance through May 19, 2025. The contract is not set aside and is a firm-fixed price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $9,893.07 and a performance period through June 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,907.28 firm fixed-price contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,731.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $2,650.95 and a performance period ending on May 19, 2025. The contract is not set aside and was awarded on May 16, 2025. Amerisourcebergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,762.40, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of March 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,077,688 tablets of the medication dapagliflozin 10 mg. The $5,948.05 firm fixed-price contract has an ultimate completion date of April 30, 2025 and is not a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,067.74 and a completion date of May 13, 2025. The contract is a firm-fixed price delivery order, indicating a predetermined price for the products. This award is not designated as a set-aside...